CD171 (L1CAM), Human Antibody from MILTENYI BIOTEC B.V. & Co. KG
Search, find, compare suppliers for anti-CD171 (L1CAM), Human antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CD171 (L1CAM), Human |
| Clone | REA163 |
| Host Species | Recombinant Human |
| Reactive Species | human |
| Isotype | IgG1 |
| Format | PE-Vio 615 conjugate |
| Size | 100 tests in 200 µL |
| Concentration | 1:50 |
| Applications | Flow cytometry |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | CD171 (L1CAM) Antibody, anti-human, PE-Vio® 615, REAfinity™. Clone REA163 recognizes human CD171, a single-pass type I membrane glycoprotein belonging to the immunoglobulin superfamily. Also known as L1 cell adhesion molecule (L1CAM) or NCAM-L1, CD171 belongs to a subgroup of cell adhesion molecules, which consist of six Ig-like domains, five fibronectin type III (FNIII)-like domains, a transmembrane region, and a cytoplasmic domain. Expression of CD171 is found on tetanus-toxin positive neurons, endothelial cells, certain epithelial cells, reticular fibroblasts, and several malignant tumors including colon and breast carcinomas, colon melanoma, tumor cells of neuronal, and mesothelial origin, where a role of CD171 in augmenting tumor growth has been demonstrated. Thus, CD171 is considered a novel marker for carcinoma progression. CD171 displays binding to a number of ligands including homophilic interaction with itself and heterophilic binding to integrins, other cell adhesion molecules, extracellular matrix molecules. It is involved in the development of the nervous system and regulates processes such as neuron-neuron adhesion, myelination, axonal guidance, and neuronal migration. | Additional information: Clone REA163 displays negligible binding to Fc receptors. | |
| Immunogen | n/a |
| Other Names | L1CAM, CAML1, HSAS, MASA, MIC5, N-CAM-L1, S10, SPG1 |
| Gene, Accession # | Gene ID: 3897 |
| Catalog # | 130-123-489 |
| Price | $335 |
| Order / More Info | CD171 (L1CAM), Human Antibody from MILTENYI BIOTEC B.V. & Co. KG |
| Product Specific References | Rathjen, F. G. et al. (1984) Immunocytological and biochemical characterization of a new neuronal cell surface component (L1 antigen) which is involved in cell adhesion. EMBO J. 3 (1): 1-10. | Schaefer, A. W. et al. (1999) Activation of the MAPK signal cascade by the neural cell adhesion molecule L1 requires L1 internalization. J. Biol. Chem. 274: 37965-37973. | Needham, L. K. et al. (2001) Cytoplasmic domain mutations of the L1 cell adhesion molecule reduce L1-ankyrin interactions. J. Neurosci. 21: 1490-1500. | Huszar, M. et al. (2006) Expression profile analysis in multiple human tumors identifies L1 (CD171) as a molecular marker for differential diagnosis and targeted therapy. Hum. Pathol. 37 (8): 1000-1008. |
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-StraÃe 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197
macs@miltenyibiotec.de
https://www.miltenyibiotec.com
Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies